Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Analyst Ratings for Treace Medical Concepts

Within the last quarter, Treace Medical Concepts (NASDAQ:TMCI) has observed the following analyst ratings:

Benzinga

Rivian Is A 'Show-Me-The-Money' Story But Has 'More Pieces In Place' Than Peers: Analysts React To Q1 Earnings

Electric vehicle company Rivian Automotive Inc (NASDAQ: RIVN) reported first-quarter production of 2,553 vehicles. The company delivered 1,227 vehicles in the first quarter and reported more than 90,000 net pre-orders of its Rivian R1 electric pickup truck.

Benzinga

Insurance Stocks Moving In Thursday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Short Volatility Alert: ServiceSource International

On Wednesday, shares of ServiceSource International, Inc. (NASDAQ: SREV) experienced volatile short activity. After the activity, the stock price went down 1.39% to $1.42. The overall sentiment for SREV has been Bullish.

Benzinga

Short Volatility Alert: Software Acquisition Group

On Wednesday, shares of Software Acquisition Group Inc. III (NASDAQ: SWAG) experienced volatile short activity. After the activity, the stock price moved down 0.10% to $10.00. The overall sentiment for SWAG has been Bearish.

Benzinga

COCP: Cocrystal Pharma Releases 2022 1st Quarter Results and Provides an Update on the Current Pipeline Programs

By Thomas Kerr, CFA NASDAQ:COCP READ THE FULL COCP RESEARCH REPORT

Benzinga

Expert Ratings for OncoCyte

Within the last quarter, OncoCyte (NASDAQ:OCX) has observed the following analyst ratings:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking Into Micron Technology's Recent Short Interest

Micron Technology's (NASDAQ:MU) short percent of float has fallen 14.35% since its last report. The company recently reported that it has 21.25 million shares sold short, which is 1.91% of all regular shares that are available for trading.

Benzinga

Goldman Sachs Maintains Buy Rating for Cytek Biosciences: Here's What You Need To Know

Goldman Sachs has decided to maintain its Buy rating of Cytek Biosciences (NASDAQ:CTKB) and lower its price target from $14.00 to $12.00. Shares of Cytek Biosciences are trading up 10.93% over the last 24 hours, at $8.22 per share.

Benzinga

Cowen & Co. Maintains Market Perform Rating for Beyond Meat: Here's What You Need To Know

Cowen & Co. has decided to maintain its Market Perform rating of Beyond Meat (NASDAQ:BYND) and lower its price target from $42.00 to $26.00. Shares of Beyond Meat are trading up 7.2% over the last 24 hours, at $28.05 per share.

Benzinga

Mid-Day Market Update: Dow Tumbles 350 Points; AppLovin Shares Jump

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 350 points on Thursday.

Benzinga

Stocks That Hit 52-Week Highs On Thursday

On Thursday, 5 companies set new 52-week highs.

Benzinga

58 Stocks Moving In Thursday's Mid-Day Session

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Benzinga

Moderna Concludes FDA Submission For Its COVID-19 Shot In Adolescents, Kids

Reuters reported that Moderna Inc (NASDAQ:MRNA) had made required submissions to the FDA for emergency use authorization of its COVID-19 vaccine in adolescents and children. An advisory panel of experts to the U.S. drug regulator will meet in June to review the request. Related: FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Micron, Affirm Holdings And 'The Only FANG Worth Buying' Will Be Featured On 'Mad Money' Tonight

Several prominent CEOs are set to be featured on "Mad Money" Thursday night with Jim Cramer. Here's a look at the lineup:

Benzinga

Camtek Clocks 35% Revenue Growth In Q1 Backed By Robust Order Flow Amid China's Covid Lockdown, Global Tensions

Camtek Ltd (NASDAQ:CAMT) reported first-quarter FY22 revenue growth of 35% year-on-year to $77.17 million, marginally beating the consensus of $77 million. The non-GAAP gross margin expanded 130 bps to 52%. The non-GAAP operating margin expanded by 160 bps to 28.8%. Non-GAAP EPS of $0.44 missed the consensus of $0.45. The company held $428.3…

Benzinga

Microsoft Postpones 2 Xbox Games

Microsoft Corp's (NASDAQ:MSFT) ZeniMax Media postponed two of its anticipated video games until the first half of 2023, marking a slip for the Xbox. ZeniMax unit Bethesda Softworks is producing Starfield, a space-themed action role-playing game, Bloomberg reports. ZeniMax's Arkane Austin is developing Redfall, a first-person shooter. Microsoft’s Xbox Game Pass subscription service has 25 million…

Benzinga

Hut 8 Mining Registers 67% Revenue Growth In Q1

Hut 8 Mining Corp (NASDAQ:HUT) (TSX:HUT) reported first-quarter FY22 revenue growth of 67% year-on-year to C$53.3 million. EPS was C$0.31. Hut 8 currently has an installed hash rate of 2.54 EH/s, up 27% from December 31. As of March 31, Hut 8 had a total Bitcoin balance of 6,460 with a market…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Bank Of America Is Turning Bullish On This ESG Stock

Atlantica Sustainable Infrastructure PLC (NASDAQ: AY) is a “defensive play” in a highly volatile market, according to BofA Securities.

Benzinga

Why Are Cullinan Oncology Shares Rising Today?

Taiho Pharmaceutical Co Ltd will co-develop and co-commercialize Cullinan Oncology Inc (NASDAQ: CGEM) lead program, CLN-081/TAS6417.

Benzinga

8 Analysts Have This to Say About BRP Group

Within the last quarter, BRP Group (NASDAQ:BRP) has observed the following analyst ratings:

Benzinga

Preview: ProPhase Labs's Earnings

ProPhase Labs (NASDAQ:PRPH) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that ProPhase Labs will report an earnings per share (EPS) of $0.38.

Benzinga

6 Analysts Have This to Say About FTC Solar

Within the last quarter, FTC Solar (NASDAQ:FTCI) has observed the following analyst ratings:

Benzinga

Recap: InflaRx Q1 Earnings

InflaRx (NASDAQ:IFRX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings InflaRx missed estimated earnings by 5.88%, reporting an EPS of $-0.36 versus an estimate of $-0.34.

Benzinga

Aadi Bioscience: Q1 Earnings Insights

Aadi Bioscience (NASDAQ:AADI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Aadi Bioscience beat estimated earnings by 7.04%, reporting an EPS of $-0.66 versus an estimate of $-0.71.

1 … 542 543 544 545

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.